E-LIB Suche - Ergebnisse für: Albert, Gary

1

Strong CD4+ T-Cell Responses to Ancestral and Variant Spike..:

Fries, Louis ; Formica, Neil ; Mallory, Raburn M...
The Journal of Infectious Diseases. 228 (2023) 6 - p. 734-741 , 2023

Link: https://doi.org/10.1093/..

2

Different dose regimens of a SARS-CoV-2 recombinant spike p..:

Formica, Neil ; Mallory, Raburn ; Albert, Gary...
PLOS Medicine. 18 (2021) 10 - p. e1003769 , 2021

Link: https://doi.org/10.1371/..

3

CORRESPONDENCE:

Albert, Gary
The South Carolina Historical Magazine. 116 (2015) 4 - p. 322 ff. , 2015

Link: https://www.jstor.org/st..

4

Phase 2 clinical trial of PBI-4050 in patients with idiopat..:

Khalil, Nasreen ; Manganas, Helene ; Ryerson, Christopher J....
European Respiratory Journal. 53 (2018) 3 - p. 1800663 , 2018

Link: https://doi.org/10.1183/..

5

Behavior modification. An empirical approach to self-contro:

Glover, John A. ; Gary, Albert L. , 1979

Exemplar: Zentrale:Magazin 02.E.5125

6

Self-disclosure as an exchange process:

Worthy, Morgan ; Gary, Albert L. ; Kahn, Gay M.
Journal of Personality and Social Psychology. 13 (1969) 1 - p. 59-63 , 1969

Link: https://doi.org/10.1037/..

7

Safety and immunogenicity following a homologous booster do..:

Mallory, Raburn M ; Formica, Neil ; Pfeiffer, Susan...
The Lancet Infectious Diseases. , 2022

Link: http://hdl.handle.net/10..

8

Efficacy of the NVX-CoV2373 Covid-19 Vaccine Against the B...:

Shinde, Vivek ; Bhikha, Sutika ; Hoosain, Zaheer...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8091623/. , 2021

Link: http://www.ncbi.nlm.nih...

9

Phase 2 clinical trial of PBI-4050 in patients with idiopat..:

Khalil, Nasreen ; Manganas, Helene ; Ryerson, Christopher J...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6422836/. , 2019

Link: http://www.ncbi.nlm.nih...

10

Plasminogen replacement therapy for the treatment of childr..:

Shapiro, Amy D ; Nakar, Charles ; Parker, Joseph M...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5865234/. , 2018

Link: http://www.ncbi.nlm.nih...

11

Different dose regimens of a SARS-CoV-2 recombinant spike p..:

Neil Formica ; Raburn Mallory ; Gary Albert...
https://doi.org/10.1371/journal.pmed.1003769. , 2021

Link: https://doi.org/10.1371/..

12

Solicited local and systemic AEs:

Neil Formica (11512548) ; Raburn Mallory (11512551) ; Gary Albert (11512554)...
https://figshare.com/articles/figure/Solicited_local_and_systemic_AEs_/16723167. , 2021

Link: https://doi.org/10.1371/..

13

Demographic characteristics of the participants at enrollme..:

Neil Formica (11512548) ; Raburn Mallory (11512551) ; Gary Albert (11512554)...
https://figshare.com/articles/dataset/Demographic_characteristics_of_the_participants_at_enrollment_Safety_Analysis_Set_/16723176. , 2021

Link: https://doi.org/10.1371/..

14

SARS-CoV-2 anti-spike IgG and neutralizing antibody respons..:

Neil Formica (11512548) ; Raburn Mallory (11512551) ; Gary Albert (11512554)...
https://figshare.com/articles/figure/SARS-CoV-2_anti-spike_IgG_and_neutralizing_antibody_responses_at_Day_35_/16723170. , 2021

Link: https://doi.org/10.1371/..

15

Anti-S protein serum IgG antibody immune responses for NVX-..:

Neil Formica (11512548) ; Raburn Mallory (11512551) ; Gary Albert (11512554)...
https://figshare.com/articles/dataset/Anti-S_protein_serum_IgG_antibody_immune_responses_for_NVX-CoV2373_study_treatments_by_study_group_and_age_18_to_84_years_or_age_subgroup_18_to_59_years_and_60_to_84_years_/16723179. , 2021

Link: https://doi.org/10.1371/..